Incensole acetate reduces depressive-like behavior and modulates hippocampal BDNF and CRF expression of submissive animals

Journal of Psychopharmacology

Volumn 26, Issue 12, 2012, Pages 1584-1593

  Moussaieff, Arieh ^a   Gross, Moshe ^a,b,c   Nesher, Elimelech ^a,b   Tikhonov, Tatiana ^a   Yadid, Gal ^b   Pinhasov, Albert ^a,c  

^a ARIEL UNIVERSITY   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c R and D Center Samaria and Jordan Rift   (Israel)

Author keywords

brain derived neurotrophic factor (BDNF); corticosterone; corticotrophin releasing factor (CRF); depression; dominant submissive relationship (DSR); Incensole acetate

Indexed keywords

ANTIDEPRESSANT AGENT; BOSWELLIA CARTERII EXTRACT; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR IV; BRAIN DERIVED NEUROTROPHIC FACTOR VI; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; FRANKINCENSE; INCENSOLE ACETATE; MESSENGER RNA; PAROXETINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; BOSWELLIA; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DOMINANT SUBMISSIVE RELATIONSHIP; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; FORCED SWIMMING TEST; GENE EXPRESSION; HIPPOCAMPUS; HORMONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LOW DRUG DOSE; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE DRUG DOSE; UPREGULATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN-RELEASING HORMONE; DEPRESSION; DISEASE MODELS, ANIMAL; DITERPENES; DOMINANCE-SUBORDINATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HIPPOCAMPUS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; PITUITARY-ADRENAL SYSTEM; SWIMMING; TIME FACTORS; UP-REGULATION;

EID: 84870467267     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112458729     Document Type: Article

References (79)

1. Aid T, Kazantseva A, Piirsoo M, et al. Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res. 2007 ; 85: 525-535
2. Archer J. Tests for emotionality in rats and mice: A review. Anim Behav. 1973 ; 21: 205-235
3. Autelitano DJ, Cohen DR. CRF stimulates expression of multiple fos and jun related genes in the AtT-20 corticotroph cell. Mol Cell Endocrinol. 1996 ; 119: 25-35
4. Autelitano DJ, Sheppard KE. Corticotrope responsiveness to glucocorticoids is modulated via rapid CRF-mediated induction of the proto-oncogene c-fos. Mol Cell Endocrinol. 1993 ; 94: 111-119
5. Binder EB, Nemeroff CB. The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry. 2010 ; 15: 574-588
6. Binneman B, Feltner D, Kolluri S, et al. A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression. Am J Psychiatry. 2008 ; 165: 617-620
7. Brouwer JP, Appelhof BC, Hoogendijk WJ, et al. Thyroid and adrenal axis in major depression: a controlled study in outpatients. Eur J Endocrinol. 2005 ; 152: 185-191
8. Chen C. Recent advances in small molecule antagonists of the corticotropin-releasing factor type-1 receptor-focus on pharmacology and pharmacokinetics. Curr Med Chem. 2006 ; 13: 1261-1282
9. Chen Y, Bender RA, Brunson KL, et al. Modulation of dendritic differentiation by corticotropin-releasing factor in the developing hippocampus. Proc Natl Acad Sci U S A. 2004 ; 101: 15782-15787
10. Coric V, Feldman HH, Oren DA, et al. Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depress Anxiety. 2010 ; 27: 417-425
11. Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: Recent developments and future needs. Trends Pharmacol Sci. 2002 ; 23: 238-245
12. de Kloet ER. Hormones, brain and stress. Endocr Regul. 2003 ; 37: 51-68
13. de Kloet ER. About stress hormones and resilience to psychopathology. J Neuroendocrinol. 2008 ; 20: 885-892
14. de Kloet ER, Joels M, Holsboer F. Stress and the brain: From adaptation to disease. Nat Rev Neurosci. 2005 ; 6: 463-475
15. de Kloet ER, Karst H, Joels M. Corticosteroid hormones in the central stress response: Quick-and-slow. Front Neuroendocrinol. 2008 ; 29: 268-272
16. Depino AM, Gross C. Simultaneous assessment of autonomic function and anxiety-related behavior in BALB/c and C57BL/6 mice. Behav Brain Res. 2007 ; 177: 254-260
17. Dias BG, Banerjee SB, Duman RS, et al. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology. 2003 ; 45: 553-563
18. Duman RS. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med. 2004 ; 5: 11-25
19. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006 ; 59: 1116-1127
20. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry. 1997 ; 54: 597-606
21. Dwivedi Y, Rizavi HS, Pandey GN. Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: Differential regulation of specific exons by antidepressants and corticosterone. Neuroscience. 2006 ; 139: 1017-1029
22. Fanselow MS, Dong HW. Are the dorsal and ventral hippocampus functionally distinct structures?. Neuron. 2010 ; 65: 7-19
23. Feder Y, Nesher E, Ogran A, et al. Selective breeding for dominant and submissive behavior in Sabra mice. J Affect Disord. 2010 ; 126: 214-222
24. Flandreau EI, Ressler KJ, Owens MJ, et al. Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus. Psychoneuroendocrinology. 2012 ; 37: 27-38
25. Hamm S, Bleton J, Connan J, et al. A chemical investigation by headspace SPME and GC-MS of volatile and semi-volatile terpenes in various olibanum samples. Phytochemistry. 2005 ; 66: 1499-1514
26. Hauger RL, Risbrough V, Oakley RH, et al. Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann N Y Acad Sci. 2009 ; 1179: 120-143
27. Herbert J. Neurosteroids, brain damage, and mental illness. Exp Gerontol. 1998 ; 33: 713-727
28. Ivy AS, Rex CS, Chen Y, et al. Hippocampal dysfunction and cognitive impairments provoked by chronic early-life stress involve excessive activation of CRH receptors. J Neurosci. 2010 ; 30: 13005-13015
29. Kagamiishi Y, Yamamoto T, Watanabe S. Hippocampal serotonergic system is involved in anxiety-like behavior induced by corticotropin-releasing factor. Brain Res. 2003 ; 991: 212-221
30. Kalueff AV, Keisala T, Minasyan A, et al. Temporal stability of novelty exploration in mice exposed to different open field tests. Behav Processes. 2006 ; 72: 104-112
31. Kaplan GB, Vasterling JJ, Vedak PC. Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: Role in pathogenesis and treatment. Behav Pharmacol. 2010 ; 21: 427-437
32. Kasahara M, Groenink L, Olivier B, et al. Corticotropin-releasing factor (CRF) over-expression down-regulates hippocampal dopamine receptor protein expression and CREB activation in mice. Neuro Endocrinol Lett. 2011 ; 32: 193-198
33. Kavushansky A, Ben-Shachar D, Richter-Levin G, et al. Physical stress differs from psychosocial stress in the pattern and time-course of behavioral responses, serum corticosterone and expression of plasticity-related genes in the rat. Stress. 2009 ; 12: 412-425
34. Kling MA, Coleman VH, Schulkin J. Glucocorticoid inhibition in the treatment of depression: Can we think outside the endocrine hypothalamus?. Depress Anxiety. 2009 ; 26: 641-649
35. Kovacs KJ, Sawchenko PE. Regulation of stress-induced transcriptional changes in the hypothalamic neurosecretory neurons. J Mol Neurosci. 1996a ; 7: 125-133
36. Kovacs KJ, Sawchenko PE. Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J Neurosci. 1996b ; 16: 262-273
37. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008 ; 455: 894-902
38. Lee EH, Chang SY, Chen AY. CRF facilitates NE release from the hippocampus: A microdialysis study. Neurosci Res. 1994 ; 19: 327-330
39. MacQueen G, Frodl T. The hippocampus in major depression: Evidence for the convergence of the bench and bedside in psychiatric research?. Mol Psychiatry. 2011 ; 16: 252-264
40. Malatynska E, Knapp RJ. Dominant-submissive behavior as models of mania and depression. Neurosci Biobehav Rev. 2005 ; 29: 715-737
41. Malatynska E, Goldenberg R, Shuck L, et al. Reduction of submissive behavior in rats: A test for antidepressant drug activity. Pharmacology. 2002 ; 64: 8-17
42. Malatynska E, Pinhasov A, Creighton CJ, et al. Assessing activity onset time and efficacy for clinically effective antidepressant and antimanic drugs in animal models based on dominant-submissive relationships. Neurosci Biobehav Rev. 2007a ; 31: 904-919
43. Malatynska E, Pinhasov A, Crooke JJ, et al. Reduction of dominant or submissive behaviors as models for antimanic or antidepressant drug testing: Technical considerations. J Neurosci Methods. 2007b ; 165: 175-182
44. Malatynska E, Rapp R, Harrawood D, et al. Submissive behavior in mice as a test for antidepressant drug activity. Pharmacol Biochem Behav. 2005 ; 82: 306-313
45. Malatynska E, Kostowski W. The effect of antidepressant drugs on dominance behavior in rats competing for food. Pol J Pharmacol Pharm. 1984 ; 36: 531-540
46. Manji HK, Drevets WC, Charney DS. The cellular neurobiology of depression. Nat Med. 2001 ; 7: 541-547
47. Marti O, Gavalda A, Gomez F, et al. Direct evidence for chronic stress-induced facilitation of the adrenocorticotropin response to a novel acute stressor. Neuroendocrinology. 1994 ; 60: 1-7
48. Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci. 2007 ; 10: 1089-1093
49. Molendijk ML, Bus BA, Spinhoven P, et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry. 2011 ; 16: 1088-1095
50. Moussaieff A, Mechoulam R. Boswellia resin: From religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials. J Pharm Pharmacol. 2009 ; 61: 1281-1293
51. Moussaieff A, Shohami E, Kashman Y, et al. Incensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activation. Mol Pharmacol. 2007 ; 72: 1657-1664
52. Moussaieff A, Rimmerman N, Bregman T, et al. Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain. FASEB J. 2008 ; 22: 3024-3034
53. Musazzi L, Cattaneo A, Tardito D, et al. Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants. BMC Neurosci. 2009 ; 10: 48
54. Nair A, Vadodaria KC, Banerjee SB, et al. Stressor-specific regulation of distinct brain-derived neurotrophic factor transcripts and cyclic AMP response element-binding protein expression in the postnatal and adult rat hippocampus. Neuropsychopharmacology. 2007 ; 32: 1504-1519
55. Nesher E, Peskov V, Rylova A, et al. Comparative analysis of the behavioral and biomolecular parameters of four mouse strains. J Mol Neurosci. 2012 ; 46: 276-284
56. Nestler EJ, Gould E, Manji H, et al. Preclinical models: Status of basic research in depression. Biol Psychiatry. 2002 ; 52: 503-528
57. Nikisch G. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function. Neuro Endocrinol Lett. 2009 ; 30: 11-16
58. Pace TW, Miller AH. Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann N Y Acad Sci. 2009 ; 1179: 86-105
59. Pariante CM. Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids. Ann N Y Acad Sci. 2009 ; 1179: 144-152
60. Pariante CM, Thomas SA, Lovestone S, et al. Do antidepressants regulate how cortisol affects the brain?. Psychoneuroendocrinology. 2004 ; 29: 423-447
61. Parker KJ, Schatzberg AF, Lyons DM. Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav. 2003 ; 43: 60-66
62. Petit-Demouliere B, Chenu F, Bourin M. Forced swimming test in mice: A review of antidepressant activity. Psychopharmacology (Berl). 2005 ; 177: 245-255
63. Pinhasov A, Crooke J, Rosenthal D, et al. Reduction of Submissive Behavior Model for antidepressant drug activity testing: Study using a video-tracking system. Behav Pharmacol. 2005a ; 16: 657-664
64. Pinhasov A, Ilyin SE, Crooke J, et al. Different levels of gamma-synuclein mRNA in the cerebral cortex of dominant, neutral and submissive rats selected in the competition test. Genes Brain Behav. 2005b ; 4: 60-64
65. Pinhasov A, Nesher E, Gross M, et al. The role of the PACAP signaling system in depression. Curr Pharm Des. 2011 ; 17: 990-1001
66. Regev L, Tsoory M, Gil S, et al. Site-specific genetic manipulation of amygdala corticotropin-releasing factor reveals its imperative role in mediating behavioral response to challenge. Biol Psychiatry. 2012 ; 71: 317-326
67. Reichenstein M, Rehavi M, Pinhasov A. Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action. J Mol Neurosci. 2008 ; 36: 330-338
68. Russo-Neustadt AA, Chen MJ. Brain-derived neurotrophic factor and antidepressant activity. Curr Pharm Des. 2005 ; 11: 1495-1510
69. Saruta J, Sato S, Tsukinoki K. The role of neurotrophins related to stress in saliva and salivary glands. Histol Histopathol. 2010 ; 25: 1317-1330
70. Sathanoori M, Dias BG, Nair AR, et al. Differential regulation of multiple brain-derived neurotrophic factor transcripts in the postnatal and adult rat hippocampus during development, and in response to kainate administration. Brain Res Mol Brain Res. 2004 ; 130: 170-177
71. Shneider Y, Shtrauss Y, Yadid G, et al. Differential expression of PACAP receptors in postnatal rat brain. Neuropeptides. 2010 ; 44: 509-514
72. South P, Smith A, Guidry C, et al. Effect of physical restraint on oxidative stress in mice fed a selenium and vitamin E deficient diet. Biol Trace Elem Res. 2006 ; 109: 293-299
73. Stern CM. Corticotropin-releasing factor in the hippocampus: Eustress or distress?. J Neurosci. 2011 ; 31: 1935-1936
74. Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009 ; 10: 397-409
75. Uppal A, Singh A, Gahtori P, et al. Antidepressants: Current strategies and future opportunities. Curr Pharm Des. 2010 ; 16: 4243-4253
76. Valdez GR. CRF receptors as a potential target in the development of novel pharmacotherapies for depression. Curr Pharm Des. 2009 ; 15: 1587-1594
77. Warner-Schmidt JL, Duman RS. Hippocampal neurogenesis: Opposing effects of stress and antidepressant treatment. Hippocampus. 2006 ; 16: 239-249
78. Wiedenmayer CP, Magarinos AM, McEwen BS, et al. Age-specific threats induce CRF expression in the paraventricular nucleus of the hypothalamus and hippocampus of young rats. Horm Behav. 2005 ; 47: 139-150
79. Zhang JJ, Swiergiel AH, Palamarchouk VS, et al. Intracerebroventricular infusion of CRF increases extracellular concentrations of norepinephrine in the hippocampus and cortex as determined by in vivo voltammetry. Brain Res Bull. 1998 ; 47: 277-284